{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:29:24Z","timestamp":1773185364919,"version":"3.50.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001338"],"award-info":[{"award-number":["82001338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2020JJ4854"],"award-info":[{"award-number":["2020JJ4854"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ40934"],"award-info":[{"award-number":["2021JJ40934"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2021JJ30989"],"award-info":[{"award-number":["2021JJ30989"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined the relationship between body mass index (BMI), the metabolically healthy status, and subclinical atherosclerosis in the NAFLD population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data from asymptomatic NAFLD subjects who participated in a routine health check-up examination were collected. Participants were stratified by BMI (cutoff values: 24.0\u201327.9\u2009kg\/m<jats:sup>2<\/jats:sup> for overweight and \u226528.0\u2009kg\/m<jats:sup>2<\/jats:sup> for obesity) and metabolic status, which was defined by Adult Treatment Panel III criteria. Subclinical atherosclerosis was evaluated by brachial-ankle pulse wave velocity (baPWV) in 27,738 participants and by carotid plaque in 14,323 participants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Within each BMI strata, metabolically unhealthy subjects had a significantly higher prevalence of subclinical atherosclerosis than metabolically healthy subjects, whereas fewer differences were observed across subjects within the same metabolic category. When BMI and metabolic status were assessed together, a metabolically unhealthy status was the main contributor to the association of clinical phenotypes with the subclinical atherosclerosis burden (all <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). When BMI and metabolic abnormalities were assessed separately, the incidence of subclinical disease did not increase across BMI categories; however, it increased with an increase in the number of metabolic abnormalities (0, 1, 2 and \u22653).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A metabolically healthy status in NAFLD patients was closely correlated with subclinical atherosclerosis, beyond that of the BMI-based obesity phenotype. The application of metabolic phenotyping strategies could enable more precise classification in evaluating cardiovascular risk in NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2023.1104859","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:15:56Z","timestamp":1695197756000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population"],"prefix":"10.3389","volume":"10","author":[{"given":"Yaqin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","article-title":"Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health","volume":"5","author":"Eslam","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016","volume":"288","author":"Zou","year":"2020","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1111\/jgh.15156","article-title":"Global epidemiology of lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"35","author":"Lu","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","author":"Younossi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/nu14040815","article-title":"The impact of dietary diversity, lifestyle, and blood lipids on carotid atherosclerosis: a cross-sectional study","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.jacc.2019.12.039","article-title":"Trajectories of age-related arterial stiffness in Chinese men and women","volume":"75","author":"Lu","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.ackd.2017.10.005","article-title":"Glomerular filtration rates in Asians","volume":"25","author":"Teo","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"ref15","volume-title":"Hepatic steatosis ultrasound images assessment procedures manual","year":"2010"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","article-title":"Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary","volume":"22","author":"Farrell","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Treatment of high blood cholesterol in executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1210\/jc.2018-01321","article-title":"Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the Framingham Heart Study","volume":"104","author":"Echouffo-Tcheugui","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2016.01.032","article-title":"HbA1c is significantly associated with arterial stiffness but not with carotid atherosclerosis in a community-based population without type 2 diabetes: the Dong-gu study","volume":"247","author":"Lee","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.pcd.2020.07.007","article-title":"The association of subclinical atherosclerosis with prediabetes is stronger in people with dyslipidaemia than in those with normoglycaemia: a cross-sectional study in Chinese adults","volume":"14","author":"Zhu","year":"2020","journal-title":"Prim Care Diabetes"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep4.1199","article-title":"Association of hepatic steatosis with subclinical atherosclerosis: systematic review and meta-analysis","volume":"2","author":"Kapuria","year":"2018","journal-title":"Hepatol Commun"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4250\/jcu.2012.20.3.126","article-title":"Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients","volume":"20","author":"Kang","year":"2012","journal-title":"J Cardiovasc Ultrasound"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/01.ATV.0000160613.57985.18","article-title":"Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study","volume":"25","author":"Brea","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1097\/MD.0000000000000654","article-title":"Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index","volume":"94","author":"Chung","year":"2015","journal-title":"Medicine"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000341248","article-title":"The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals","volume":"123","author":"Kim","year":"2012","journal-title":"Cardiology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jdmv.2021.03.008","article-title":"Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: a case-control study in Algerian population","volume":"46","author":"Taharboucht","year":"2021","journal-title":"J Med Vasc"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","article-title":"Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?","volume":"71","author":"Younes","year":"2021","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/1871529x11202020113","article-title":"A review of obesity and body fat distribution and its relationship to cardio-metabolic risk in men and women of Chinese origin","volume":"12","author":"Lear","year":"2012","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.amjmed.2018.02.002","article-title":"Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham Heart Study","volume":"131","author":"Lee","year":"2018","journal-title":"Am J Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/hep.28985","article-title":"Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease","volume":"65","author":"Bril","year":"2017","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review","volume":"23","author":"Cariou","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","author":"Lee","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1210\/clinem\/dgab644","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between non-alcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"716783","DOI":"10.3389\/fnut.2021.716783","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"8","author":"Houttu","year":"2021","journal-title":"Front Nutr"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"709683","DOI":"10.3389\/fnut.2021.709683","article-title":"Effect of intermittent fasting on non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"8","author":"Yin","year":"2021","journal-title":"Front Nutr"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.3390\/nu14153186","article-title":"Adherence to Mediterranean diet and NAFLD in patients with metabolic syndrome: the FLIPAN study","volume":"14","author":"Montemayor","year":"2022","journal-title":"Nutrients"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.clnu.2018.11.030","article-title":"A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease","volume":"38","author":"Chen","year":"2019","journal-title":"Clin Nutr"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"795391","DOI":"10.3389\/fnut.2021.795391","article-title":"Association of serum vitamin C with NAFLD and MAFLD among adults in the United States","volume":"8","author":"Xie","year":"2022","journal-title":"Front Nutr"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1210\/jc.2004-2240","article-title":"Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity","volume":"90","author":"Bugianesi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/hep.26390","article-title":"Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?","volume":"58","author":"Kwok","year":"2013","journal-title":"Hepatology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/ehjci\/jex239","article-title":"Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans","volume":"19","author":"Sillesen","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1104859\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:16:04Z","timestamp":1695197764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2023.1104859\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":53,"alternative-id":["10.3389\/fnut.2023.1104859"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2023.1104859","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"article-number":"1104859"}}